EPA TRI Chemical

Thiabendazole

CAS Number: 148-79-8

Total releases
90.4K lbs
Number of facilities
11
Carcinogen
No
PBT substance
No
Verify at EPA TRI →

According to the EPA Toxics Release Inventory, Thiabendazole (CAS 148-79-8) is disclosed by 11 Form R facilities totaling 90.4K lbs of reported releases. TRI pounds are self-reported disclosure totals, not a measured public-health risk score.

View saved records

Thiabendazole (CAS 148-79-8) is a chemical tracked by the EPA Toxics Release Inventory (TRI) program under Section 313 of the Emergency Planning and Community Right-to-Know Act. The TRI requires industrial facilities above specified threshold quantities to disclose annual manufacturing, processing, and otherwise-used volumes, along with quantities released to air, water, land, and off-site transfers.

A carcinogen flag, when present on other chemicals in this database, reflects an assessment from EPA, IARC, or the National Toxicology Program rather than a TRI-specific determination. The largest individual disclosure in the current dataset comes from TRADEBE TREATMENT & RECYCLING OF TN in TN at 38.1K lbs.

TRI volumes are self-reported estimates, not measured stack emissions, and each pound counts equally regardless of chemical toxicity, so total pounds should not be equated with total risk. Inclusion of a chemical or facility in the TRI does not itself establish a health hazard; it documents the public right-to-know record. Consult EPA's IRIS (Integrated Risk Information System) and the Agency for Toxic Substances and Disease Registry for health-effect summaries.

MIXED pathway mix

Thiabendazole: how the 90.4K lbs splits

90.4K lbs across all reported pathways

  • Off-site Transfers46.3K lbs51.3%
  • Water Discharges32.8K lbs36.3%
  • Land Disposal11.2K lbs12.4%
  • Air Releases67 lbs0.1%

Thiabendazole's 90.4K lbs Form-R total is MIXED, with off-site transfers making up 51.3% of the bar. Next segment: water discharges at 36.3%.

Trend & Where It's Reported

Reported Release Trend

Between 2019 and 2023, cumulative annual Thiabendazole releases across all reporting facilities decreased by 49% (42.8K lbs → 21.7K lbs). Year-to-year swings reflect facility openings/closures and reporting changes as much as underlying activity.

Geographic Concentration

Reporting for Thiabendazole is concentrated: Tennessee accounts for 42.2% of the reported total (1 facility). Next: Alabama.

  • Tennessee 38.1K lbs
  • Alabama 20.8K lbs
  • Pennsylvania 19.2K lbs
  • Oklahoma 11.2K lbs
  • Nebraska 1.1K lbs
Industry Sources

Reporting for Thiabendazole is highly concentrated by industry: Hazardous Waste facilities account for 54.5% of the reported total (3 facilities). Next: Paper.

  • Hazardous Waste 49.3K lbs
  • Paper 32.8K lbs
  • Chemicals 8.3K lbs

Which facilities release the most of this chemical?

Facilities with the largest reported releases of Thiabendazole. Up to 50 shown.

# Facility Release (lbs)
1 Tradebe Treatment & Recycling of Tn
38.1K lbs
2 Gold Bond Building Products - Anniston
20.8K lbs
3 Gold Bond Building Products - Milton
15.8K lbs
4 Lanxess Corp Neville Island
12.9K lbs
5 Clean Harbors Lone Mountain LLC Lone Mountain Facility
11.2K lbs
6 Syngenta Crop Protection Llc-Omaha Plant
1.1K lbs
7 Veolia N.a. Inc.
4 lbs
8 Uraseal Inc
2 lbs
9 Gowan Milling LLC
0 lbs
10 Schirm USA Inc.
0 lbs
11 Albaugh Inc.
0 lbs
12 Tec Edison LLC
0 lbs

Frequently Asked Questions

What is Thiabendazole in the EPA TRI?
Thiabendazole (CAS Number: 148-79-8) is a chemical tracked by the EPA Toxic Release Inventory (TRI) program. It is not marked as a carcinogen in the TRI classification set. 11 facilities in the United States report releasing this chemical to the EPA.
How much Thiabendazole is disclosed in U.S. TRI filings?
U.S. facilities have reported a total of 90.4K lbs of Thiabendazole releases to the EPA Toxic Release Inventory across 11 facilities. Release quantities are self-reported estimates covering air, water, land, and off-site transfers. They are disclosure totals, not toxicity-weighted harm scores.
How does EPA TRI classify Thiabendazole?
Thiabendazole is not marked as a carcinogen in the TRI classification set. TRI classification flags document inventory listing status; they are not a site-specific exposure or health diagnosis. For health-effect summaries see EPA IRIS and ATSDR toxicological profiles.
Which facilities disclose the most Thiabendazole?
Tradebe Treatment & Recycling of Tn in TN reports the largest disclosed release of Thiabendazole in this dataset, at 38.1K lbs. Most reporting facilities for this chemical fall under hazardous waste. Release data is self-reported annually to the EPA under the TRI program. View the full list of 11 facilities on this page.
What is the CAS number for Thiabendazole?
The CAS (Chemical Abstracts Service) Registry Number for Thiabendazole is 148-79-8. CAS numbers are unique numerical identifiers assigned to every chemical substance described in the open scientific literature. This identifier is used to search scientific databases and regulatory filings.

Health Information

Data comes from the EPA Toxic Release Inventory (TRI) program. Release quantities are self-reported by facilities and may represent estimates. The total shown aggregates reports across all facilities and reporting years.

PlainEnviro presents this data without advocacy framing. The presence of a chemical in the TRI database does not by itself indicate a health risk at current exposure levels. For health-related questions about specific chemical exposures, consult your local health agency or a toxicologist.

Related

Data sourced from the U.S. Environmental Protection Agency (EPA). See our methodology for details. Retrieved and formatted by PlainEnviro

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the EPA Toxic Release Inventory (TRI). Consult a qualified professional before making decisions based on this data.